Browse Articles

In this study, Imani et al. investigate whether a new proprietary herbal formulation, HF1, can inhibit expression of immune suppressor protein PD-L1. PD-L1 is a transmembrane protein that can be expressed by cancer cells to assist in their ability to avoid attacks from the immune system. Work from this study demonstrates that HF1 treatment can reduce expression of PD-L1 in cultured cancer cells, implicating HF1 as a potential new cancer therapy.

The authors employ computational protein design to identify a mini-protein with the potential to enhance binding of the tight junction protein, claudin-5, at the blood-blood barrier with therapeutic potential for neurodegenerative diseases.

Zeolithic imidazolate framework-8 (ZIF-8) is a specific metal-organic framework that has favorable qualities for use in an air filter and is known to be capable of adsorbing particulate matter. Therefore, the objective of this experiment was to determine the effectiveness of ZIF-8 in adsorbing polar, gaseous air pollutants, specifically nitrogen dioxide and hydrogen sulfide. In order to determine effectiveness, the percent change in concentration for various gases after the application of ZIF-8 crystals was measured via Fourier-transform infrared spectroscopy (FTIR). The work highlights crystals as a potentially promising alternative or addition to current filter materials to reduce atmospheric pollution.

Polo-like kinase 1 (Plk1) is a master regulator of mitosis, initiating key steps of cell cycle regulation, and its overexpression is associated with certain types of cancer. In this study, the authors carefully designed peptides that were able to bind to Plk1 at a location that is important for its proper localization and function. Future studies could further develop these peptides to selectively target Plk1 in cancer cells and induce mitotic arrest.